The BER pathway—whose members include the PARP genes—is upregulated in the breast, prostate, ovarian and prostate cancer subsets with HRD, as a secondary protective DNA repair mechanism against HRD [31]. This evidence concerns the gene PARP1 and prostate carcinoma.